Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Angoulvant

Showing results (151-160 of 216) with videos related to

Pageof 22
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2009
Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient miceDenis Angoulvant, Shafie Fazel, Richard D Weisel, et al.
Diabetes & Metabolism|April 17, 2025
Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes SocietyPatrick Henry, Sophie Jacqueminet, Gilles Lemesle, et al.
Clinical Kidney Journal|February 22, 2020
Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic viewCédric Pinier, Philippe Gatault, Laurent Fauchier, et al.
Journal of Cardiology|May 14, 2018
Atrial fibrillation, intra-ventricular thrombus, and other anticoagulant indications relationship with adverse outcomes in acute anterior myocardial infarction patientsAsma Bourezg, Thomas Bochaton, Nathan Mewton, et al.
JACC. Cardiovascular Interventions|February 19, 2021
Timing of Coronary Revascularization and Transcatheter Aortic Valve Replacement: An Observational Nationwide Cohort AnalysisPierre Lantelme, Arnaud Bisson, Thibaud Lacour, et al.
European Journal of Preventive Cardiology|October 26, 2018
Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registryVictoria Tea, Marc Bonaca, Chekrallah Chamandi, et al.
Critical Care (London, England)|September 24, 2014
Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) RegistryNadia Aissaoui, Etienne Puymirat, Tabassome Simon, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 1, 2005
Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factorShafie Fazel, Liwen Chen, Richard D Weisel, et al.
Scientific Reports|October 5, 2023
Human peripheral blood mononuclear cells display a temporal evolving inflammatory profile after myocardial infarction and modify myocardial fibroblasts phenotypeElodie Miquelestorena-Standley, Ana Valéria Vinhais da Silva, Marina Monnier, et al.
The Journal of Invasive Cardiology|April 22, 2022
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT RegistryJanusz Lipiecki, Rajiv Rampat, Christophe Piot, et al.
Pageof 22

Showing results (151-160 of 216) with videos related to

Sort By:
Pageof 22
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2009
Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient miceDenis Angoulvant, Shafie Fazel, Richard D Weisel, et al.
Diabetes & Metabolism|April 17, 2025
Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes SocietyPatrick Henry, Sophie Jacqueminet, Gilles Lemesle, et al.
Clinical Kidney Journal|February 22, 2020
Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic viewCédric Pinier, Philippe Gatault, Laurent Fauchier, et al.
Journal of Cardiology|May 14, 2018
Atrial fibrillation, intra-ventricular thrombus, and other anticoagulant indications relationship with adverse outcomes in acute anterior myocardial infarction patientsAsma Bourezg, Thomas Bochaton, Nathan Mewton, et al.
JACC. Cardiovascular Interventions|February 19, 2021
Timing of Coronary Revascularization and Transcatheter Aortic Valve Replacement: An Observational Nationwide Cohort AnalysisPierre Lantelme, Arnaud Bisson, Thibaud Lacour, et al.
European Journal of Preventive Cardiology|October 26, 2018
Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registryVictoria Tea, Marc Bonaca, Chekrallah Chamandi, et al.
Critical Care (London, England)|September 24, 2014
Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) RegistryNadia Aissaoui, Etienne Puymirat, Tabassome Simon, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 1, 2005
Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factorShafie Fazel, Liwen Chen, Richard D Weisel, et al.
Scientific Reports|October 5, 2023
Human peripheral blood mononuclear cells display a temporal evolving inflammatory profile after myocardial infarction and modify myocardial fibroblasts phenotypeElodie Miquelestorena-Standley, Ana Valéria Vinhais da Silva, Marina Monnier, et al.
The Journal of Invasive Cardiology|April 22, 2022
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT RegistryJanusz Lipiecki, Rajiv Rampat, Christophe Piot, et al.
Pageof 22